Cencora Return on Tangible Equity 2010-2023 | COR
Current and historical return on tangible equity values for Cencora (COR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Cencora Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $1.87B | $-12.98B | -13.88% |
| 2023-09-30 | $1.75B | $-13.34B | -12.98% |
| 2023-06-30 | $1.69B | $-13.50B | -12.70% |
| 2023-03-31 | $1.62B | $-14.01B | -12.33% |
| 2022-12-31 | $1.73B | $-12.95B | -13.51% |
| 2022-09-30 | $1.70B | $-12.77B | -13.15% |
| 2022-06-30 | $1.84B | $-12.72B | -14.01% |
| 2022-03-31 | $1.73B | $-12.78B | -12.78% |
| 2021-12-31 | $1.61B | $-13.40B | -12.93% |
| 2021-09-30 | $1.54B | $-13.70B | -13.51% |
| 2021-06-30 | $-3.74B | $-14.16B | 36.24% |
| 2021-03-31 | $-3.75B | $-8.65B | 47.11% |
| 2020-12-31 | $-3.22B | $-9.08B | 45.87% |
| 2020-09-30 | $-3.41B | $-9.43B | 55.00% |
| 2020-06-30 | $1.57B | $-4.65B | -29.39% |
| 2020-03-31 | $1.58B | $-4.93B | -27.96% |
| 2019-12-31 | $0.65B | $-5.78B | -10.96% |
| 2019-09-30 | $0.86B | $-6.01B | -14.03% |
| 2019-06-30 | $0.96B | $-5.93B | -15.32% |
| 2019-03-31 | $0.93B | $-6.02B | -14.60% |
| 2018-12-31 | $1.19B | $-6.46B | -18.41% |
| 2018-09-30 | $1.66B | $-6.56B | -26.09% |
| 2018-06-30 | $1.08B | $-6.44B | -16.83% |
| 2018-03-31 | $0.85B | $-6.40B | -13.35% |
| 2017-12-31 | $0.98B | $-6.03B | -15.31% |
| 2017-09-30 | $0.36B | $-6.81B | -5.52% |
| 2017-06-30 | $0.85B | $-6.36B | -12.97% |
| 2017-03-31 | $1.15B | $-6.35B | -17.03% |
| 2016-12-31 | $1.35B | $-6.80B | -19.51% |
| 2016-09-30 | $1.43B | $-6.83B | -20.02% |
| 2016-06-30 | $1.64B | $-7.11B | -24.15% |
| 2016-03-31 | $1.51B | $-6.84B | -24.47% |
| 2015-12-31 | $0.39B | $-7.75B | -7.12% |
| 2015-09-30 | $-0.14B | $-5.52B | 3.45% |
| 2015-06-30 | $-0.43B | $-4.54B | 14.43% |
| 2015-03-31 | $-0.66B | $-4.21B | 29.44% |
| 2014-12-31 | $0.03B | $-1.73B | -2.16% |
| 2014-09-30 | $0.27B | $-1.53B | -19.46% |
| 2014-06-30 | $0.26B | $-1.50B | -19.60% |
| 2014-03-31 | $0.44B | $-1.35B | -36.13% |
| 2013-12-31 | $0.31B | $-1.25B | -26.11% |
| 2013-09-30 | $0.43B | $-1.18B | -37.37% |
| 2013-06-30 | $0.55B | $-1.09B | -48.17% |
| 2013-03-31 | $0.56B | $-1.17B | -54.48% |
| 2012-12-31 | $0.73B | $-1.21B | -93.55% |
| 2012-09-30 | $0.72B | $-1.07B | -137.68% |
| 2012-06-30 | $0.70B | $-0.66B | -293.72% |
| 2012-03-31 | $0.71B | $-0.16B | 4700.00% |
| 2011-12-31 | $0.71B | $-0.20B | 555.60% |
| 2011-09-30 | $0.71B | $0.06B | 342.72% |
| 2011-06-30 | $0.70B | $0.36B | 321.10% |
| 2011-03-31 | $0.68B | $0.29B | 454.18% |
| 2010-12-31 | $0.65B | $0.12B | 897.22% |
| 2010-09-30 | $0.64B | $0.11B | 4625.45% |
| 2010-06-30 | $0.63B | $0.09B | -1269.04% |
| 2010-03-31 | $0.58B | $-0.02B | -658.36% |
| 2009-12-31 | $0.54B | $-0.12B | -522.12% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.247B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.697B | 15.52 |
| ICON (ICLR) | Ireland | $24.578B | 24.24 |
| DiDi Global (DIDIY) | China | $22.930B | 0.00 |
| Avantor (AVTR) | United States | $16.557B | 22.81 |
| CochLear (CHEOY) | $13.675B | 0.00 | |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| Revvity (RVTY) | United States | $12.448B | 21.67 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.029B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 21.84 |
| Medpace Holdings (MEDP) | United States | $11.658B | 38.35 |
| Solventum (SOLV) | United States | $10.708B | 0.00 |
| Natera (NTRA) | United States | $10.700B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.966B | 52.04 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.625B | 34.43 |
| Organon (OGN) | United States | $4.601B | 4.46 |
| PACS (PACS) | United States | $3.460B | 0.00 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| Surgery Partners (SGRY) | United States | $3.044B | 28.28 |
| Life Times (LTH) | United States | $2.774B | 30.65 |
| GoodRx Holdings (GDRX) | United States | $2.631B | 133.20 |
| Premier (PINC) | United States | $2.522B | 9.23 |
| Teladoc Health (TDOC) | United States | $2.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.141B | 6.93 |
| Agilon Health (AGL) | United States | $2.121B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.816B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Establishment Labs Holdings (ESTA) | $1.325B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.273B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.947B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.617B | 4.08 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.518B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.64 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 0.00 |
| CareDx (CDNA) | United States | $0.423B | 0.00 |
| LifeMD (LFMD) | United States | $0.404B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.395B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| MultiPlan (MPLN) | United States | $0.356B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 4.14 |
| GeneDx Holdings (WGS) | United States | $0.271B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Sharecare (SHCR) | United States | $0.250B | 0.00 |
| So-Young (SY) | China | $0.131B | 44.00 |
| Biodesix (BDSX) | United States | $0.125B | 0.00 |
| Oncology Institute (TOI) | United States | $0.084B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |